We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Metoprolol Impurity A
N-Nitroso Metoprolol Impurity A
CAT No SRC-N014012
CAS No NA
Mol.F. C14H22N2O4
Mol.Wt. 282.34g/mol
INV STATUS IN STOCK
N-Nitroso Metoprolol Impurity C
N-Nitroso Metoprolol Impurity C
CAT No SRC-N014013
CAS No NA
Mol.F. C13H18N2O4
Mol.Wt. 266.3g/mol
INV STATUS IN STOCK
N-Nitroso Mirabegron
N-Nitroso Mirabegron
CAT No SRC-N014014
CAS No 3017159-61-1
Mol.F. C21H23N5O3S
Mol.Wt. 425.5 g/mol
INV STATUS IN STOCK
N-Nitroso Rac-Duloxetine
N-Nitroso Rac-Duloxetine
CAT No SRC-N014015
CAS No 2680527-91-5
Mol.F. C18H18N2O2S
Mol.Wt. 326.4 g/mol
INV STATUS IN STOCK
N-Nitroso Nebivolol
N-Nitroso Nebivolol
CAT No SRC-N014016
CAS No 1391051-68-5
Mol.F. C22H24F2N2O5
Mol.Wt. 434.4 g/mol
INV STATUS IN STOCK
N-Nitroso Paroxetine Impurity
N-Nitroso Paroxetine Impurity
CAT No SRC-N014017
CAS No 2361294-43-9
Mol.F. C19H19FN2O4
Mol.Wt. 358.4 g/mol
INV STATUS IN STOCK
N-Nitroso Sitagliptin Impurity
N-Nitroso Sitagliptin Impurity
CAT No SRC-N014018
CAS No 2892260-32-9
Mol.F. C6H6F3N5O
Mol.Wt. 221.14 g/mol
INV STATUS IN STOCK
N-Nitroso Ramipril
N-Nitroso Ramipril
CAT No SRC-N014019
CAS No NA
Mol.F. C23H31N3O6
Mol.Wt. 445.5 g/mol
INV STATUS IN STOCK
N-Nitroso-Pramipexole
N-Nitroso-Pramipexole
CAT No SRC-N014020
CAS No 3028194-78-4
Mol.F. C10H16N4OS
Mol.Wt. 240.3g/mol
INV STATUS IN STOCK
N-Nitroso Vildagliptin
N-Nitroso Vildagliptin
CAT No SRC-N014021
CAS No 3034601-47-0
Mol.F. C17H24N4O3
Mol.Wt. 332.4 g/mol
INV STATUS IN STOCK

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.